Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Azathioprine can cause hair loss and matted hair.

Polyphenolic compounds may help improve hair growth in non-scarring alopecia.

COVID-19 can cause significant hair loss.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Mesotherapy is more effective than topical spray for female hair loss treatment.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair extensions can worsen scalp conditions and should be avoided in those with alopecia.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Trichoscopy is effective for diagnosing hair and scalp disorders without invasive biopsies.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

About 61% of women who had COVID-19 experienced hair loss afterward.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.